Hepatitis C Therapy - Maxygen Announces Achievement of Milestone in Roche Alliance

Maxygen Announces Achievement of Milestone in Roche Alliance
FinanzNachrichten - Dec 14 4:48 AM
REDWOOD CITY, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Maxygen, ( Nachrichten ) Inc. announced today that it has earned a $5 million milestone in its collaboration with Roche ( Nachrichten / Aktienkurs ) to develop improved interferon alpha protein therapeutics to treat hepatitis C virus (HCV) and hepatitis B virus (HBV) infections.Save to My Web

InterMune Shares Slide From Monday High
AP via Yahoo! Finance - Jan 10 10:40 AM
InterMune Inc. shares dropped Tuesday after an investment bank said investors are being overly optimistic about the drug developer's nascent hepatitis C therapy.Save to My Web

Maxygen achieves milestone in Roche partnership
Pharmaceutical Business Review - Dec 15 5:54 PM
Maxygen has earned a $5 million milestone in its collaboration with Roche to develop improved interferon alpha protein therapeutics to treat hepatitis C and B infections.Save to My Web